Riboflavin mutants as vaccines against Actinobacillus pleuropneu

Details Riboflavin mutants as vaccines against Actinobacillus pleuropneu Riboflavin mutants as vaccines against Actinobacillus pleuropneu

1996-10-28

1999-07-20

Minnifield, Nita

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

4242351, 4242341, 424 931, 424 932, 424 934, A61K 3900, A61K 3938, A61K 4800, A61K 3902

Patent

active

059253541

ABSTRACT:
Described is a vaccine against Actinobacillus pleuropneumoniae (APP) comprising genetically defined biochemically attenuated mutant of APP that requires riboflavin and is attenuated in vivo.

REFERENCES:
patent: 4888170 (1989-12-01), Curtiss, III
patent: 5120655 (1992-06-01), Foster et al.
patent: 5332572 (1994-07-01), Ross et al.
patent: 5387744 (1995-02-01), Curtiss, III et al.
patent: 5389368 (1995-02-01), Gurtiss, III
patent: 5424065 (1995-06-01), Curtiss, III
patent: 5429818 (1995-07-01), Inzana
patent: 5456914 (1995-10-01), Stine et al.
patent: 5468485 (1995-11-01), Curtiss, III
patent: 5543304 (1996-08-01), Mulks et al.
Inzana et al, Infect + Immunity. 61/5:1682-1686, May 1993.
"Characterization of Actinobacillus pleuropneumoniae Riboflavin Biosyntesis Genes", Troy E. Fuller et al., J. Bacteriology, Dec. 1995, pp. 7265-7270.
"A Targeted Mutagenesis System For Actinobacillus pleuropneumoniae", Martha H. Mulks et al., Gene, 165 (1995) 61-66.
"Biosynthesis of Riboflavin, Biotin, Folic Acid, and Cobalamin", John B. Perkins et al., Bacillus subtilis, 23 (1993), 319-335.
"Sequencing of the Riboflavin Operon Genes From Actinobacillus.", R.E. Fuller et al., General Meeting Abstracts, 95.sup.th.
Fuller et al. Inf +Imm. 64/11:4659-4664, 1996.
Lee et al. BBRC 186/2:690-697, 1992.
Inzana, Microbial Pathogenesis 11:305-316, 1991.
Bresler et al, Genetika 5:133-138, 1969.
Fuller et al. IN: Haemophilus, Actinobacillus, and Pasteurella ed. Domachie et al pp. 229-230, 1994.
Fuller et al ASM Mtg 1995. Abstract. B-344 p. 183 1995.
Lee et al. J. Bacterial, 176/7:2100-2104, 1994.

Affiliated with

Also associated with

Rating

Riboflavin mutants as vaccines against Actinobacillus pleuropneu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Riboflavin mutants as vaccines against Actinobacillus pleuropneu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Riboflavin mutants as vaccines against Actinobacillus pleuropneu will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1319942